Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma (Q33564145)

28 July 2017

Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma (English)

1 reference

28 July 2017

0 references

1 reference

Frank Serge Lehmann

1

1 reference

28 July 2017

Francesca Trapani

2

1 reference

28 July 2017

Ida Fueglistaler

3

1 reference

28 July 2017

Luigi Maria Terracciano

4

1 reference

28 July 2017

Markus von Flüe

5

1 reference

28 July 2017

Gieri Cathomas

6

1 reference

28 July 2017

Andreas Zettl

7

1 reference

28 July 2017

Pascal Benkert

8

1 reference

28 July 2017

Daniel Oertli

9

1 reference

28 July 2017

Christoph Beglinger

10

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 2014

1 reference

World Journal of Gastroenterology

28 July 2017

1 reference

28 July 2017

20

1 reference

28 July 2017

4994-4999

1 reference

28 July 2017

17

1 reference

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Identification of S100A8 and S100A9 as serological markers for colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Colorectal cancer screening: prospects for molecular stool analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Faecal calprotectin levels in a high risk population for colorectal neoplasia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

Fecal calprotectin concentration in patients with colorectal carcinoma.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4009532

A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method

31 October 2018

1 reference

12 December 2020

Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease

1 reference

12 December 2020

Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

1 reference

12 December 2020

Sigmoid carcinoma mimicking an intra-abdominal abscess in an 111In-labeled white blood cell scan

1 reference

12 December 2020

False positive localisation of indium-111 granulocytes in colonic carcinoma

1 reference

12 December 2020

Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study

1 reference

12 December 2020

Faecal calprotectin: a novel test for the diagnosis of colorectal cancer?

1 reference

12 December 2020

Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer

1 reference

12 December 2020

Detection of recurrence after surgery for colorectal cancer

1 reference

12 December 2020

Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein

1 reference

12 December 2020

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

1 reference

12 December 2020

Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy

1 reference

12 December 2020

Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases

1 reference

12 December 2020

The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers

1 reference

12 December 2020

Local calprotectin production in colorectal cancer and polyps--active neutrophil recruitment in carcinogenesis

1 reference

12 December 2020

Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers

1 reference

12 December 2020

Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer

1 reference

12 December 2020

Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V20.I17.4994

1 reference

28 July 2017

1 reference

28 July 2017

1 reference